Overview
Status
Active
Registry date
2020-08-28
Share capital
30,000.00 PLN
Registered address
ul. Sienkiewicza 35/1, 39-300 Mielec, Poland
Financials
Revenue history (in k)
Filing timeliness
4 of 5 financial statements were filed late (the longest delay 387 days for 2024).
- 202504/08/2026
- 202406/08/2026
- 202324/11/2024
- 202213/07/2023
- 202115/10/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 27.47kMedianUSD 91.95kAverageUSD 1.38m
Net profit
This companyUSD -6.25kMedianUSD 2.66kAverageUSD 145.95k
Operating costs
This companyUSD 30.10kMedianUSD 82.81kAverageUSD 1.19m
Assets
This companyUSD 39.08kMedianUSD 39.40kAverageUSD 951.16k
Trademarks
Ingeni currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2021.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| PSYCHOPAKIET(word) | Z.530748 | 41, 44 | Refused | – | |
| Mentally(word) | Z.528487 | 41, 44 | Refused | – |
| Mark | Protected until | |
|---|---|---|
| PSYCHOPAKIET(word) | – | |
| Mentally(word) | – |
Authorized Representatives
Ewa Jadwiga Ingram – Management Board Member
Konrad Tomasz Skiba – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ewa Jadwiga Ingramage 36 | 120 | $3,241.49 | 40% |
Konrad Tomasz Skibaage 36 | 180 | $4,862.24 | 60% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-05-24.
52 1020 4913 0000 9602 0181 0993
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 16, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,048$2,048 | Agencja Rozwoju Regionalnego Marr S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Instytut Diagnostyki Molekularnej Diagmolsp. z o.o. | $46,278.17 | diagmol.pl | ||
| Fixbodysp. z o.o. | $48,400.15 | fixbody.pl | ||
| Terapposp. z o.o. | $48,218.49 | terappo.pl | ||
| Instytut Dietetyki i Żywieniasp. z o.o. | $47,346.94 | dietetyka-stanior.pl | ||
| Alfa Horsesp. z o.o. | $46,404.18 | alfahorse.pl | ||
| Gabinet Psychoterapii Swietłana Gornostajsp. z o.o. | $41,725.63 | gornostay.pro | ||
| 4x4medicsp. z o.o. | $36,373.48 | 4x4medic.pl | ||
| Kmnikosp. z o.o. | $36,673.53 | rzucam.to | ||
| Ogólnopolskie Centrum Psychoterapii i Edukacji Govindasp. z o.o. | $34,425.68 | panipsycholozka.pl | ||
| Verizensp. z o.o. | $33,374.26 | verizen.pl |
FAQ
The main business activity of Ingeni focuses on other human health activities not elsewhere classified.
The company was registered in the Polish National Court Register (KRS) on August 28, 2020.
The headquarters is located at: ul. Sienkiewicza 35, 39-300 Mielec.
The share capital of the company is PLN 30,000 (approx. $8,104).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
In 2023, the company generated total revenue of USD 42,328, representing an increase of 13.6% compared to 2022.
No, in 2023 the company was not profitable, reporting a net loss of USD 7,737. For comparison, in 2022 the loss was USD 3,490, meaning the company increased its loss by 109.0%.
The largest operating cost category falls under external services. This category amounted to USD 28,407 in 2023, representing 58% of all operating expenses.
Last updated: 2026-08-24